Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization ResVita Bio, Inc.Startup |
Active Organization ResVita Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | US | ResVita Bio, Inc.Startup | 18 Sep 2023 |